Animals were sacrificed immediately following light exposure and retinas harvested into NP-40 lysis buffer with protease inhibitors and 100 mM IAA and homogenized by sonication. Samples were incubated for one hour at 4°C with 100 μL each of TrueBlot Anti-Mouse IgG bead slurry (eBioscience, San Diego, CA). After incubation, samples were centrifuged and the pellet discarded. The supernatant of each condition was split into two equal volumes, and 2 μg of mouse anti-rhodopsin antibody (RET-P1; Santa Cruz Biotechnology), mouse anti-enolase1 (Enol2-53; gift of WC Smith, University of Florida, Gainesville, FL), or mouse anti-c-Myc antibody (9E 10; DHSB, University of Iowa, Iowa City, IA) was added to each sample along with 50 μL of bead slurry. Samples were incubated overnight at 4°C, centrifuged, and the supernatant removed. The pellet was washed with NP-40 lysis buffer, and 50 μL of 2× SDS Tris-Glycine sample loading buffer was added to bead pellets. Samples were vortexed, heated to 100°C for 10 minutes, and centrifuged. Samples were reduced using 50 mM DTT and 25 μL of sample was loaded into each lane of a 4-20% Tris-glycine gel. Immunoblots were carried out as described above using antibodies against Arr1, enolase1 (Enol2-53; 1:250), or rhodopsin (RET-P1; 80 ng/mL). Rhodopsin and enolase1 blots were probed using mouse IgG TrueBlot Ultra peroxidase-conjugated reagent (1:1000; eBioscience) to avoid detection of reduced primary antibody fragments.